Tandem Diabetes Care (TNDM) Share-based Compensation Growth (1y) (2014 - 2026)
Tandem Diabetes Care (TNDM) Share-based Compensation Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -30.44% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 31.63% |
| 10 | Tandem Diabetes Care | 1.04 Bn | 474.17 Mn | 136.79 Mn | -38.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.56% |
| Dec 31, 2025 | -28.60% |
| Sep 30, 2025 | -19.56% |
| Jun 30, 2025 | 2.99% |
| Mar 31, 2025 | 15.65% |
| Dec 31, 2024 | 23.86% |
| Sep 30, 2024 | 26.71% |
| Jun 30, 2024 | 6.40% |
| Mar 31, 2024 | 3.99% |
| Dec 31, 2023 | -6.96% |
| Sep 30, 2023 | -6.72% |
| Jun 30, 2023 | 16.24% |
| Mar 31, 2023 | 17.03% |
| Dec 31, 2022 | 42.94% |
| Sep 30, 2022 | 41.37% |
| Jun 30, 2022 | 34.41% |
| Mar 31, 2022 | 39.88% |
| Dec 31, 2021 | 28.49% |
| Sep 30, 2021 | 22.53% |
| Jun 30, 2021 | -8.79% |